First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Reaches New 1-Year High – Here’s What Happened

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s share price hit a new 52-week high on Thursday. The company traded as high as $44.19 and last traded at $43.8480, with a volume of 2,825 shares. The stock had previously closed at $43.25.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.9%

The company’s fifty day moving average is $41.60 and its 200-day moving average is $37.09. The firm has a market capitalization of $1.16 billion, a P/E ratio of 14.51 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Thursday, September 24th were given a $0.0113 dividend. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. This represents a $0.05 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Thursday, September 24th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Compass Financial Management LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter worth approximately $29,000. Flagship Harbor Advisors LLC increased its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 50.9% in the 3rd quarter. Flagship Harbor Advisors LLC now owns 8,500 shares of the company’s stock valued at $352,000 after acquiring an additional 2,868 shares during the last quarter. Vivaldi Capital Management LP raised its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock worth $433,000 after purchasing an additional 1,741 shares during the period. Englebert Financial Advisers LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $751,000. Finally, MinichMacGregor Wealth Management LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth about $968,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.